Empowering life scientists globally with high-quality biological reagents and tools critical to research, drug discovery and diagnostics
PROGRESS HAPPENS TOGETHER
Inspiring stories from world-leading scientists
PRESS RELEASE
WuXiDiagnostics and Abcam expand existing collaboration to advance companion diagnostics for cancer therapies
PRESS RELEASE
NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
PRESS RELEASE
Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM and Notice of General Meeting
PRESS RELEASE
Abcam the most Awarded Company at 2022 Industry Awards
WE ARE ABCAM
Abcam in Glassdoor’s Top 5 Best Places to Work in the UK for Second Consecutive Year
INVESTORS
Interim results for the period ended 30 June 2022
Stay up to date with Abcam
NEWS
Keep up to date with our company news
Sign-up to receive the latest corporate updates from Abcam.
EVENTS
Get information on events we are organizing and attending
Including Abcam conferences and webinars.
INVESTORS
Visit the investor centre
For corporate and share information, financial news and events, governance and resources.
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
abcam.comabcam.co.jp
abcam.cn
© Abcam plc. all rights reserved.
Abcam plc is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul